<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Perna, Amalia</dc:creator>
  <dc:creator>Alberi, Lavinia</dc:creator>
  <dc:date>2019-03-19</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Chromatin immunoprecipitation (ChIP) is an assay developed in order to define the  dynamic nature of transcription processes. This method has been widely employed to  identify methylated and acetylated DNA sequences in a variety of organs both in  animals and humans. Nevertheless, this technique is significantly less employed to  study transcriptional targets of specific nuclear signaling factors (TFs) and the data  published so far have mainly used cell culture material and have been hardly  reproduced in ex-vivo tissue. As nuclear signaling underlies important adaptive and  maladaptive responses in chronic conditions such as cancer and neurodegeneration,  there is a need for streamlining the upfront workflow of TF-ChIP for subsequent target  sequencing. Based on the typical low concentration of the signaling transcriptional  complex and the complexity/length of the ChIP Seq protocol, the field of cellular  signaling has been confronted with a major roadblock in identifying clinically relevant  targets of pathological and physiological signaling pathways. The present protocol  offers a standardized procedure for detecting signaling targets in any whole tissue or  specific dissected regions. The advantages of the protocol compared to the existing  published methods are: (1) the small amount of starting material; appropriate for  tissue subregions; (2) the optimization of DNA fragmentation from whole tissue; (3)  suitability for sparsely populated tissues (i.e., brain); (4) the specificity of the TF- targeting readout; and (5) high DNA quality for sequencing or hybridization. The  present protocol is highly detailed and can be reproduced using both fresh and fresh- frozen tissue. This is particularly relevant in the clinical setting, where specimen  integrity is often the limiting step and where transcriptional target profiling is  therapeutically relevant. The method is centered on Notch signaling but can be  applied to a variety of nuclear signaling pathways as long as specific antibodies are  available for pull down. Taken the superior yield/readout of this procedure, ChIP may  finally provide relevant information about dynamic downstream gene changes in vivo  for use in both basic research and clinical applications.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/307651</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/307651/files/alb_tcm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3389/fncel.2019.00095</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Frontiers in Cellular Neuroscience. - 2019, vol. 13, p. 95</dc:source>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">TF-ChIP Method for Tissue-Specific Gene Targets</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
